1994年,我们从加拿大引进了康基、育康,并与市内有关医院合作观察其临床疗效。现将用康基、育康治疗13例鼻咽癌患者结果报告如下。1 临床资料1.1 病例选择:①经临床和病理明确诊断为Ⅲ、Ⅳ期鼻咽癌患者。②体内有明显病灶,经 X 线、CT、B 超等检查,可明确病灶长度和体积者。本组13例病人均为初程放疗后鼻咽部有残存病灶或鼻咽部局部复发,病 In 1994, we introduced Kangji and Yukon from Canada and cooperated with relevant hospitals in the city to observe their clinical efficacy. Now with Conkey, Yu Kang treatment of 13 cases of nasopharyngeal carcinoma results reported below. 1 Clinical data 1.1 Case Selection: ① clinically and pathologically confirmed as Ⅲ, Ⅳ nasopharyngeal carcinoma patients. ② There are obvious lesions in the body, the X-ray, CT, B-ultrasound, etc., can identify the length and volume lesions. The group of 13 patients were nasopharyngeal nasopharyngeal after initial radiotherapy with residual lesions or nasopharyngeal local recurrence, disease